WT1 and diffuse intrinsic pontine glioma: In one ongoing phase I/II trial (NCT04911621), Wilms Tumor 1 (WT1) oncoprotein mRNA-loaded autologous monocyte-derived DC vaccines are being evaluated for the treatment of HGG and DIPG.